Antiviral therapies remain essential in the global response to infectious diseases, supporting the treatment and management of conditions such as HIV, hepatitis, influenza, herpes, and coronavirus infections. Rising disease prevalence, ongoing viral mutations, and the need for effective treatment options continue to strengthen pharmaceutical innovation and healthcare investments worldwide. The...